13,14-dihydroprostaglandin e1 has been researched along with 15-keto-13,14-dihydroprostaglandin e2 in 1 studies
Studies (13,14-dihydroprostaglandin e1) | Trials (13,14-dihydroprostaglandin e1) | Recent Studies (post-2010) (13,14-dihydroprostaglandin e1) | Studies (15-keto-13,14-dihydroprostaglandin e2) | Trials (15-keto-13,14-dihydroprostaglandin e2) | Recent Studies (post-2010) (15-keto-13,14-dihydroprostaglandin e2) |
---|---|---|---|---|---|
27 | 2 | 3 | 96 | 12 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hesse, WH; Peskar, BA; Rudofsky, G | 1 |
1 other study(ies) available for 13,14-dihydroprostaglandin e1 and 15-keto-13,14-dihydroprostaglandin e2
Article | Year |
---|---|
[Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Arterial Occlusive Diseases; Biotransformation; Dinoprostone; Female; Humans; Infusions, Intravenous; Male; Middle Aged | 1991 |